United Therapeutics Corporation (UTHR) institutional holders · P/E 21, rev $3.18B
United Therapeutics Corporation 13F cache, top 3 holders by reported value. Each row is the filer's newest cached 13F for quarters ended 2026-06-30 or later, share lines summed, options excluded; value is the 13F-reported market value in US dollars. Filers whose newest cached 13F is older are omitted.
| Holder | Shares | Value | Report |
|---|---|---|---|
| STATE STREET CORP | 1,898,064 | $1.03B | 2026-06-30 |
| FMR LLC | 473,409 | $256.5M | 2026-06-30 |
| Bridgewater Associates, LP | 111,326 | $60.3M | 2026-06-30 |
UTHR institutional holders FAQ
How many UTHR 13F holders are listed on this page?
This page lists 3 cached United Therapeutics Corporation (UTHR) 13F holders. Holders: https://lician.com/institutional/uthr
Who is the largest UTHR 13F holder by reported value?
The largest cached 13F holder by reported value on this page is STATE STREET CORP. Filer: https://lician.com/institutional/uthr/93751. Holders: https://lician.com/institutional/uthr
What value and shares did the largest UTHR 13F holder report?
STATE STREET CORP, the largest cached 13F holder by reported value on this page, reported 1,898,064 shares and a value of $1.03B.
What is the latest UTHR 13F report date on this page?
The latest cached 13F report date on this United Therapeutics Corporation (UTHR) holders table is Jun 30, 2026.
Which UTHR 13F holders report the largest positions?
The largest cached 13F holders by reported value on this United Therapeutics Corporation (UTHR) page are STATE STREET CORP, FMR LLC, and Bridgewater Associates, LP. Holders: https://lician.com/institutional/uthr
Where are UTHR institutional holders listed?
Cached 13F holders for United Therapeutics Corporation (UTHR) are listed at https://lician.com/institutional/uthr. Filer directory: https://lician.com/holders
What is UTHR's P/E ratio?
United Therapeutics Corporation (UTHR) trailing P/E is 21.0 on the latest cached fundamentals snapshot.
What is UTHR's latest revenue?
Latest cached United Therapeutics Corporation (UTHR) revenue for Dec 31, 2025 was $3.18B. Statements: https://lician.com/financials/uthr
Not investment advice. Cached rows, not a live tape.